Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00796562
What this trial is testing

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Who this might be right for
MDSLeukemiasLymphomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 107
Testing effectiveness (Phase 2)Looking for participantsNCT06517641
What this trial is testing

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Medical College of Wisconsin 60
Testing effectiveness (Phase 2)Study completedNCT01328496
What this trial is testing

Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen

Who this might be right for
Hematologic MalignanciesDisorder Related to TransplantationHematopoietic Malignancy
St. Jude Children's Research Hospital 14
Testing effectiveness (Phase 2)Looking for participantsNCT07599176
What this trial is testing

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Who this might be right for
Sickle Cell DiseaseBeta-thalassemia
National Heart, Lung, and Blood Institute (NHLBI) 90
Testing effectiveness (Phase 2)Study completedNCT01457885
What this trial is testing

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Who this might be right for
Acute Myeloblastic Leukemia
University of Michigan Rogel Cancer Center 75
Early research (Phase 1)Looking for participantsNCT07015684
What this trial is testing

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Who this might be right for
Sickling Disorder Due to Hemoglobin S
Columbia University 24
Large-scale testing (Phase 3)Study completedNCT00272948
What this trial is testing

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

Who this might be right for
Hepatic Veno-Occlusive Disease
European Society for Blood and Marrow Transplantation 360
Testing effectiveness (Phase 2)Study completedNCT00582933
What this trial is testing

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 96
Early research (Phase 1)Study completedNCT02916979
What this trial is testing

Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

Who this might be right for
Leukemia, LymphoidLeukemia, MyeloidMyelodysplastic Syndromes+4 more
Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00271947
What this trial is testing

Crohn's Disease Stem Cell Transplantation

Who this might be right for
Crohn's Disease
Northwestern University 1
Early research (Phase 1)Ended earlyNCT00756912
What this trial is testing

Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors

Who this might be right for
Leukemia
Eisai Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Not applicableUnknownNCT01592266
What this trial is testing

F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)

Who this might be right for
Acute Myeloid Leucemia
Hadassah Medical Organization 10
Testing effectiveness (Phase 2)Study completedNCT00587054
What this trial is testing

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Who this might be right for
Allogeneic Stem Cell TransplantLeukemiaNon-Hodgkins+3 more
Memorial Sloan Kettering Cancer Center 129
Testing effectiveness (Phase 2)Study completedNCT00564200
What this trial is testing

MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 30
Early research (Phase 1)Looking for participantsNCT04972942
What this trial is testing

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-Cell Acute Lymphoblastic Lymphoma
New York Medical College 30
Testing effectiveness (Phase 2)UnknownNCT04383067
What this trial is testing

A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients

Who this might be right for
Metastatic Urothelial Carcinoma
Sheba Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07290413
What this trial is testing

Photobiomodulation for the Prevention of Oral Mucositis

Who this might be right for
Oral Mucositis
Brigham and Women's Hospital 78
Testing effectiveness (Phase 2)Study completedNCT00912223
What this trial is testing

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

Who this might be right for
Lymphoma, Non-Hodgkin
Medical College of Wisconsin 65
Next Page